{"address1": "3963 Maple Avenue", "address2": "Suite 350", "city": "Dallas", "state": "TX", "zip": "75219", "country": "United States", "phone": "972 499 3350", "website": "https://instilbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It also develops AXN-2510/IMM2510 that is in Phase 1b/2clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. ImmuneOnco is conducting a Phase 1 open label trial in China of AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors that have failed prior therapies, including triple-negative breast cancer, or TNBC, squamous non-small cell lung cancer (squamous NSCLC), hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors including soft tissue sarcomas and thymic cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bronson  Crouch", "age": 51, "title": "Chairman & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1140189, "exercisedValue": 0, "unexercisedValue": 35349}, {"maxAge": 1, "name": "Dr. Sandeep  Laumas M.D.", "age": 55, "title": "CFO & Chief Business Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 741521, "exercisedValue": 0, "unexercisedValue": 61910}, {"maxAge": 1, "name": "Dr. Andres A. Gutierrez M.D., Ph.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.36, "open": 17.36, "dayLow": 16.61, "dayHigh": 17.74, "regularMarketPreviousClose": 17.36, "regularMarketOpen": 17.36, "regularMarketDayLow": 16.61, "regularMarketDayHigh": 17.74, "payoutRatio": 0.0, "beta": 1.74, "forwardPE": -1.4101077, "volume": 81961, "regularMarketVolume": 81961, "averageVolume": 90255, "averageVolume10days": 69540, "averageDailyVolume10Day": 69540, "bid": 16.78, "ask": 17.49, "bidSize": 1, "askSize": 1, "marketCap": 111070648, "fiftyTwoWeekLow": 9.62, "fiftyTwoWeekHigh": 92.0, "fiftyDayAverage": 20.6207, "twoHundredDayAverage": 24.152645, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 84641600, "profitMargins": 0.0, "floatShares": 2670001, "sharesOutstanding": 6525890, "sharesShort": 547298, "sharesShortPriorMonth": 499941, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.083900005, "heldPercentInsiders": 0.1282, "heldPercentInstitutions": 0.80385, "shortRatio": 6.03, "shortPercentOfFloat": 0.1451, "impliedSharesOutstanding": 6525890, "bookValue": 25.964, "priceToBook": 0.655523, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -74135000, "trailingEps": -11.39, "forwardEps": -12.07, "lastSplitFactor": "1:20", "lastSplitDate": 1701993600, "enterpriseToEbitda": -1.502, "52WeekChange": 0.5444646, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 17.02, "targetHighPrice": 180.0, "targetLowPrice": 51.0, "targetMeanPrice": 113.66667, "targetMedianPrice": 110.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 113315000, "totalCashPerShare": 17.364, "ebitda": -56348000, "totalDebt": 86886000, "quickRatio": 14.351, "currentRatio": 15.764, "debtToEquity": 51.28, "returnOnAssets": -0.1272, "returnOnEquity": -0.37512, "freeCashflow": -26628750, "operatingCashflow": -55696000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -11.39, "epsForward": -12.07, "epsCurrentYear": -11.51, "priceEpsCurrentYear": -1.4787142, "fiftyDayAverageChange": -3.6007004, "fiftyDayAverageChangePercent": -0.17461582, "twoHundredDayAverageChange": -7.1326447, "twoHundredDayAverageChangePercent": -0.29531527, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": -1.9585261, "regularMarketPrice": 17.02, "shortName": "Instil Bio, Inc.", "longName": "Instil Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "regularMarketChange": -0.34000015, "regularMarketDayRange": "16.61 - 17.74", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 90255, "fiftyTwoWeekLowChange": 7.4000006, "fiftyTwoWeekLowChangePercent": 0.76923084, "fiftyTwoWeekRange": "9.62 - 92.0", "fiftyTwoWeekHighChange": -74.979996, "fiftyTwoWeekHighChangePercent": -0.81499994, "fiftyTwoWeekChangePercent": 54.446457, "earningsTimestamp": 1741095000, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_638929728", "displayName": "Instil Bio", "trailingPegRatio": null}